Literature DB >> 10797617

Regulation of Fas and FasL expression on rat Schwann cells.

G Wohlleben1, S M Ibrahim, J Schmidt, K V Toyka, H P Hartung, R Gold.   

Abstract

Although the PNS belongs to the immune privileged sites, it can become a target of immune attacks by invading T cells, causing inflammation and destruction. Yet the PNS also has a protective potential by eliminating the inflammatory cells via apoptosis. In analogy with other immune-protected sites, participation of the apoptosis-inducing Fas/FasL molecules could play an important role. To assess the possible involvement of the Fas/FasL system in T-cell apoptosis in the PNS of the rat, we characterized Fas and FasL expression on neonatal rat Schwann cells (SC) in vitro. Cells were stimulated in vitro with interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), or a combination of both. We observed upregulation of FasL expression under the influence of IFN-gamma, while adding TNF-alpha alone to the culture medium had no effect. IFN-gamma and TNF-alpha acted synergistically, leading to an increased FasL expression that reached its maximum 70 h after cytokine exposure, as shown by FACS analysis, SDS-PAGE, and Western blot. Fas expression on untreated SC showed fluctuating levels, while addition of IFN-gamma and TNF-alpha suppressed Fas expression completely. These findings are in accord with recently published results showing Fas and FasL expression on malignant human cells, derived from brain tumors and upregulation of FasL on astrocytes after exposure to IFN-gamma and TNF-alpha. Furthermore, FasL-expressing SC could be revealed by immunostaining of sciatic nerve from Lewis rats suffering from experimental autoimmune neuritis (EAN). We suggest that Fas/FasL expression on SC may contribute to the elimination of invading autoreactive T cells in the PNS in concert with other immune defense mechanisms. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797617

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  7 in total

Review 1.  Neuronal elements in the pathogenesis of type 1 diabetes.

Authors:  Hubert Tsui; Shawn Winer; George Jakowsky; H-Michael Dosch
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

3.  The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kapp B signaling.

Authors:  Carme Sole; Xavier Dolcet; Miguel F Segura; Humberto Gutierrez; Maria-Teresa Diaz-Meco; Raffaella Gozzelino; Daniel Sanchis; Jose R Bayascas; Carme Gallego; Jorge Moscat; Alun M Davies; Joan X Comella
Journal:  J Cell Biol       Date:  2004-11-01       Impact factor: 10.539

4.  FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.

Authors:  Zhahirul Islam; Israt Jahan; Rijwan U Ahammad; Mohammad Shahnaij; Shamsun Nahar; Quazi D Mohammad
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

5.  Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.

Authors:  Violetta Zujovic; Cédric Doucerain; Antoine Hidalgo; Corinne Bachelin; François Lachapelle; Robert Weissert; Christine Stadelmann; Chris Linington; Anne Baron-Van Evercooren
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

6.  PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cells.

Authors:  Sheng Han; Xinxin Tie; Lingxuan Meng; Yunjie Wang; Anhua Wu
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

7.  Krüppel-like factor 6 rendered rat Schwann cell more sensitive to apoptosis via upregulating FAS expression.

Authors:  Ting Gui; Yueming Wang; Lixing Zhang; Wenjing Wang; Hao Zhu; Wenlong Ding
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.